title: Modeling somatic evolution in tumorigenesis.
abstract: Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a selective advantage, allowing lineages derived from the mutated cell to outcompete other cells. Although molecular cell biology has substantially advanced cancer research, our understanding of the evolutionary dynamics that govern tumorigenesis is limited. This paper analyzes the computational implications of cancer progression presented by Hanahan and Weinberg in The Hallmarks of Cancer. We model the complexities of tumor progression as a small set of underlying rules that govern the transformation of normal cells to tumor cells. The rules are implemented in a stochastic multistep model. The model predicts that (i) early-onset cancers proceed through a different sequence of mutation acquisition than late-onset cancers; (ii) tumor heterogeneity varies with acquisition of genetic instability, mutation pathway, and selective pressures during tumorigenesis; (iii) there exists an optimal initial telomere length which lowers cancer incidence and raises time of cancer onset; and (iv) the ability to initiate angiogenesis is an important stage-setting mutation, which is often exploited by other cells. The model offers insight into how the sequence of acquired mutations affects the timing and cellular makeup of the resulting tumor and how the cellular-level population dynamics drive neoplastic evolution.
authors.affiliation: Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. spencers@mit.edu
authors.forename: Sabrina L
authors.initials: SL
authors.lastname: Spencer
authors.forename: Ryan A
authors.initials: RA
authors.lastname: Gerety
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Pienta
authors.forename: Stephanie
authors.initials: S
authors.lastname: Forrest
mesh_terms: D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D003198:Computer Simulation; D019143:Evolution, Molecular; D006801:Humans; D008957:Models, Genetic; D009363:Neoplasm Proteins / Q000235:genetics*; D009369:Neoplasms / Q000098:blood supply* / Q000235:genetics*; D009389:Neovascularization, Pathologic / Q000235:genetics*
chemical_list: D009363:Neoplasm Proteins